AMVUTTRA (vutrisiran) Play by Play Initiative Highlights Former Athletes Stories to Shine a Light on the Often-Missed Signs of ATTR-CM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the launch of AMVUTTRA (vutrisiran) Play by Play, a U.S. educational initiative featuring former professional athletes living with the cardiomyopathy of transthyretin-mediated amyloidosis (ATTR-CM...